Americord Registry
Provider of private perinatal biobanking services including collection, manual minimal-manipulation processing, and long-term cryogenic storage of cord blood, cord tissue, placental tissue, and exosome preparations. Operates an in-house laboratory with external accreditation and multiple state and federal registrations, and provides insured cold-chain logistics, chain-of-custody management, and clinical sample release support for therapeutic use.
Industries
Nr. of Employees
small (1-50)
Americord Registry
New York, New York, United States, North America
Patents
Compositions and methods for transport and preservation of biological material
US-11589574-B2
View Details
Compositions and methods for transport and preservation of biological material
US-11589574-B2
View DetailsServices
Enrollment, kit delivery, bedside collection, laboratory processing using manual closed-system workflows, cryogenic storage, and clinical release of umbilical cord blood units.
Collection and cryopreservation of umbilical cord tissue to preserve mesenchymal stromal cell–containing tissue for investigational and potential therapeutic use.
Processing and cryopreservation of placental tissue and extraction-ready preparations containing placenta-derived cells for potential therapeutic applications.
Isolation and cryogenic storage of extracellular vesicle preparations from perinatal sources for research and investigational applications.
Provision and expedited shipment of medical collection kits to birthing facilities or homes, with insured courier pickup and expedited transport to the laboratory.
Enrollment, kit delivery, bedside collection, laboratory processing using manual closed-system workflows, cryogenic storage, and clinical release of umbilical cord blood units.
Collection and cryopreservation of umbilical cord tissue to preserve mesenchymal stromal cell–containing tissue for investigational and potential therapeutic use.
Processing and cryopreservation of placental tissue and extraction-ready preparations containing placenta-derived cells for potential therapeutic applications.
Isolation and cryogenic storage of extracellular vesicle preparations from perinatal sources for research and investigational applications.
Provision and expedited shipment of medical collection kits to birthing facilities or homes, with insured courier pickup and expedited transport to the laboratory.
Expertise Areas
- Perinatal biobanking (cord blood, cord tissue, placental tissue, exosomes)
- Cryopreservation and long-term cryogenic storage management
- Manual closed-system processing and minimal-manipulation tissue preservation
- Mesenchymal and hematopoietic cell handling and ex vivo expansion support
Key Technologies
- Vapor-phase liquid nitrogen cryostorage (-196°C)
- Closed-system manual processing workflows
- Minimal-manipulation perinatal tissue preservation
- Multi-compartment cryogenic storage containers
News & Updates
Announcement of external AABB accreditation for the company's in-house laboratory.
Report of relocation of the in-house laboratory to a facility in Somerset, New Jersey designed to meet regulatory and processing needs.
Press release announcing the addition of exosome isolation and storage services expanding offerings beyond newborn biobanking.
Publicized engraftment guarantee policy providing funding to locate an alternate stem cell source if a stored cord blood graft fails to engraft (terms apply).
Reported operational metrics including more than 22,000 cryogenically stored units and 12 successful releases since 2008 (company-reported).
Achievement of AABB accreditation for in-house processing laboratory.
Announcement of external AABB accreditation for the company's in-house laboratory.
Report of relocation of the in-house laboratory to a facility in Somerset, New Jersey designed to meet regulatory and processing needs.
Press release announcing the addition of exosome isolation and storage services expanding offerings beyond newborn biobanking.
Publicized engraftment guarantee policy providing funding to locate an alternate stem cell source if a stored cord blood graft fails to engraft (terms apply).
Reported operational metrics including more than 22,000 cryogenically stored units and 12 successful releases since 2008 (company-reported).
Achievement of AABB accreditation for in-house processing laboratory.